You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
JavaScript Required
JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Skip to Content
Accessibility Information
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Maryland Department of Health
Prevention and Health Promotion Administration
Prevention and Health Promotion Administration
Currently selected
Home
Help & Support
Connect With Us
Section Menu
Quick Links
About
What's New
Job Board
Programs
Healthy People
Thriving Communities
Data, Information, and Plans
Reports
Share Your Voice
Left_Content
Main_Content
Zika
I
nf
ormation for Clinicians
MDH Clinician Guidance
(each date will link to the clinician letter PDF)
11/21/2107:
Updated MDH Zika Recommendations, Guidelines (subsequently superseded by
7/17/2018 Guidelines
), and
Lab Form Instructions
6/7/2017:
Maryland Zika Epidemiology, New Clinical Tools, and Updated Travel Guidance
3/27/2017:
Updated Zika Travel and Testing Guidance and
Yellow Fever in Brazil
12/23/2016
:
FDA Safety Communication: Zika Virus IgM ELISA by InBios International Inc.
12/16/2016:
CDC Guidance Regarding Women Living In or Traveling to Brownsville, TX
Recent Literature Related to Zika Virus Infection and Adverse Pregnancy Outcomes:
Birth Defects Among Fetuses and Infants of US Women
Zika Virus RNA Replication and Persistence in Brain and Placental Tissue
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Monitoring and Preventing Congenital Zika Syndrome
Description of 13 Infants Born with Zika Virus Infection Without Microcephaly
10/3/2016:
Interim Guidance: Preconception Counseling and Prevention of Sexual Transmission
Travel Considerations for
Southeast Asia
and
Miami-Dade County, FL
Characteristics of Children with Zika Virus Disease Acquired Postnatally
9/7/2016:
DHMH Zika Virus Testing Algorithm [superseded]
8/24/2016:
Updated Guidance: Evaluation & Management of Infants with Possible Zika Infections
Guidance for Travel and Testing Related to Miami-Dade, FL [superseded]
7/28/2016
: Updated Testing Algorithms [superseded]
Updated Interim Guidance and Recommendations:
For Providers Caring for Pregnant Women with Possible Zika Virus Exposure
For the Prevention of Sexual Transmission of Zika Virus
For Testing of Infant Specimens at Time of Birth [superseded]
6/28/2016:
Criteria for Testing Non-Travelers During Mosquito Season
6/7/2016:
Mosquito Season and Updated Counseling Recommendations
Updated Guidance on Performance and Interpretation of Serological Testing
5/11/2016:
Commercial Availability of Zika Virus Testing
Reporting of Possible Zika Cases, Including Children Born to Women Potentially
Infected with Zika Virus
Counseling Patients on Prevention of Mosquito Bites
Reporting of Rash Illness Clusters Possibly Due to Locally Transmitted Zika Virus
Infection
3/25/2016:
Interim Guidance for Pregnant and Reproductive Age Women [superseded]
Updated Interim Guidance for Preventing Sexual Transmission [superseded]
2/12/2016:
Testing for the Zika Virus at the Maryland Laboratories Administration
[superseded]
2/5/2016:
Updated Testing Guidance for Pregnant Women
Updated Sexual Prevention Guidance [superseded]
1/20/2016:
Updated Zika Virus Information
12/30/2015:
Zika Virus Information
CDC Clinician Guidance
CDC Updates Guidance for Pregnant Women and Women and Men of Reproductive Age for Zika Virus Infection Related to the Ongoing Investigation of Local Mosquito-borne Zika Virus Transmission in Miami-Dade County, Florida
CDC Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure
CDC Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection
CDC Interim Guidance for Interpretation of Zika Virus Antibody Test Results
CDC Guidance Document 'Zika Virus: Information for Clinicians'
CDC MMWR: Preventing Transmission of Zika Virus in Labor and Delivery Settings Through Implementation of Standard Precautions
Center_Content